Predict your next investment

Private Equity
ffandco.com

See what CB Insights has to offer

Investments

20

Portfolio Exits

11

Funds

3

Service Providers

1

About Ferrer Freeman & Company

Ferrer Freeman & Company is a private equity firm located in Greenwich, CT focuses exclusively on growth capital investments in the healthcare industry. FFC invests in established companies with significant growth opportunities and entrepreneurial management teams. FFC has a demonstrated track record of leveraging its healthcare network and experience to help build market leading organizations.

Ferrer Freeman & Company Headquarter Location

10 Glenville Street

Greenwich, Connecticut, 06831,

United States

203-532-8011

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Ferrer Freeman & Company

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find Ferrer Freeman & Company in 1 Expert Collection, including Pharma Startups.

P

Pharma Startups

5,090 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

Latest Ferrer Freeman & Company News

Ferrer Freeman & Company Announces Personnel Updates

Jan 25, 2013

January 25, 2013 07:00 AM Eastern Standard Time NEW YORK--( BUSINESS WIRE )--Ferrer Freeman & Company (“FFC”), a private equity firm focused on growth capital investments in the healthcare industry, announced today the promotions of Ryan Kirkpatrick and Justin Yang to Principal and the hiring of Michael O’Rourke as an Associate. Mr. Kirkpatrick joined FFC in 2007. Prior to FFC, Mr. Kirkpatrick was the healthcare analyst at Melleos Capital Management, a New York-based asset management firm investing in public equities. He is a member of the Board of Directors of Biotix Inc. and a former Director of Ernest Health, Inc. and Amerita, Inc., FFC portfolio companies that were sold in 2012. Mr. Kirkpatrick was also an observer of the Board of Vitalize Consulting Services, Inc. Mr. Kirkpatrick holds a B.A. in Molecular Biology from Princeton University and an M.B.A. with a focus in Healthcare Management and Finance from The Wharton School. Mr. Yang joined FFC in 2006. Prior to FFC, Mr. Yang was a financial analyst at UBS Investment Bank in the Healthcare Investment Banking group. He is member of the Board of Directors of Medical Depot, Inc. and worked on FFC’s investments in AgaMatrix, Inc., Arcadia Solutions, LLC, GeneraMedix, Inc., Preferred Care Partners, Inc., and Reliant Renal Care, Inc. Mr. Yang holds a B.A. in Computer Science and Economics from Cornell University. Mr. O’Rourke joins FFC from CIT's Healthcare Investment Banking group. While at CIT, he was responsible for originating and executing Leveraged Finance and M&A advisory transactions for public and private middle market healthcare companies, including the debt recapitalization of Ernest Health, Inc. in June 2011. At FFC, he will be responsible for sourcing investments, due diligence and supporting portfolio management. Mr. O’Rourke holds a Bachelor of Science in Finance and Accounting from the McIntire School of Commerce at the University of Virginia. David Freeman, co-founder of FFC, commented, “The promotions of Ryan and Justin demonstrate the important contributions they have made at FFC; they are integral members of a strong and experienced investment team. Both have played a critical role in deal sourcing and value creation for our portfolio companies for over five years.” Mr. Freeman added, “Additionally, Michael joins the firm at an exciting time in our history, and his experience working across multiple healthcare industry sectors will bring significant value to our team as we continue to pursue new investments.” About Ferrer Freeman & Company Ferrer Freeman & Company, LLC, is a private equity firm located in Greenwich, CT focused exclusively on growth capital investments in the healthcare industry. Since its founding in 1995, FFC has invested over $900 million in 36 portfolio companies. FFC invests in established companies with significant growth opportunities and entrepreneurial management teams. FFC has a demonstrated track record of leveraging its comprehensive healthcare network and decades of experience to help build market leading organizations. More information on FFC is available at www.ffandco.com . Contacts

Ferrer Freeman & Company Investments

20 Investments

Ferrer Freeman & Company has made 20 investments. Their latest investment was in Reliant Renal Care as part of their Unattributed VC on December 12, 2007.

CBI Logo

Ferrer Freeman & Company Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

12/24/2007

Unattributed VC

Reliant Renal Care

$50M

Yes

12/5/2007

Series C

WaveForm Diabetes

$23.66M

No

6/14/2006

Private Equity

K2M Group Holdings

$21.5M

No

4/24/2006

Unattributed VC

Subscribe to see more

$99M

Subscribe to see more

10

2/4/2005

Series C

Subscribe to see more

$99M

Subscribe to see more

10

Date

12/24/2007

12/5/2007

6/14/2006

4/24/2006

2/4/2005

Round

Unattributed VC

Series C

Private Equity

Unattributed VC

Series C

Company

Reliant Renal Care

WaveForm Diabetes

K2M Group Holdings

Subscribe to see more

Subscribe to see more

Amount

$50M

$23.66M

$21.5M

$99M

$99M

New?

Yes

No

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

10

10

Ferrer Freeman & Company Portfolio Exits

11 Portfolio Exits

Ferrer Freeman & Company has 11 portfolio exits. Their latest portfolio exit was National Surgical Healthcare on August 31, 2017.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

8/31/2017

Acquired

$991

4

11/13/2013

Acq - Fin

1

7/18/2011

Acquired

00/00/0000

Subscribe to see more

Subscribe to see more

$991

Subscribe to see more

10

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

Date

8/31/2017

11/13/2013

7/18/2011

00/00/0000

00/00/0000

Exit

Acquired

Acq - Fin

Acquired

Subscribe to see more

Subscribe to see more

Companies

Subscribe to see more

Subscribe to see more

Valuation

$991

$991

Acquirer

Subscribe to see more

Subscribe to see more

Sources

4

1

10

10

Ferrer Freeman & Company Acquisitions

5 Acquisitions

Ferrer Freeman & Company acquired 5 companies. Their latest acquisition was Arcadia Healthcare Solutions on November 14, 2012.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

11/14/2012

Series C

$72.5M

Acq - Fin

1

2/17/2006

Subscribe to see more

$991

$99M

Subscribe to see more

10

6/15/2005

Subscribe to see more

$99M

Subscribe to see more

10

7/4/2003

Subscribe to see more

$99M

Subscribe to see more

10

8/16/1999

Acquired

Subscribe to see more

$991

$99M

Subscribe to see more

10

Date

11/14/2012

2/17/2006

6/15/2005

7/4/2003

8/16/1999

Investment Stage

Series C

Acquired

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$991

$991

Total Funding

$72.5M

$99M

$99M

$99M

$99M

Note

Acq - Fin

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

10

10

10

10

Ferrer Freeman & Company Fund History

3 Fund Histories

Ferrer Freeman & Company has 3 funds, including FFC Partners III LP.

Closing Date

Fund

Fund Type

Status

Amount

Sources

7/25/2004

FFC Partners III LP

Industry Focused

$415M

1

12/31/2000

FFC Partners II LP

Subscribe to see more

$99M

10

1/1/1996

FFC Partners I LP

Subscribe to see more

$99M

10

Closing Date

7/25/2004

12/31/2000

1/1/1996

Fund

FFC Partners III LP

FFC Partners II LP

FFC Partners I LP

Fund Type

Industry Focused

Subscribe to see more

Subscribe to see more

Status

Amount

$415M

$99M

$99M

Sources

1

10

10

Ferrer Freeman & Company Service Providers

1 Service Provider

Ferrer Freeman & Company has 1 service provider relationship

Service Provider

Associated Rounds

Provider Type

Service Type

Counsel

General Counsel

Service Provider

Associated Rounds

Provider Type

Counsel

Service Type

General Counsel

Partnership data by VentureSource

Ferrer Freeman & Company Team

4 Team Members

Ferrer Freeman & Company has 4 team members, including current Founding Partner, David A. Freeman.

Name

Work History

Title

Status

David A. Freeman

Founding Partner

Current

Tricia Summers

Chief Financial Officer

Former

Lorri Garnett

Controller

Former

Robert T Thompson

HealthCare Capital Partners

General Partner

Former

Name

David A. Freeman

Tricia Summers

Lorri Garnett

Robert T Thompson

Work History

HealthCare Capital Partners

Title

Founding Partner

Chief Financial Officer

Controller

General Partner

Status

Current

Former

Former

Former

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.